Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in the Treatment of Dysthymic Disorder
NCT00220701Phase 4Completed
- Sponsor
- St. Luke's-Roosevelt Hospital Center
- Start
- Jun 2002
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in persistent depressive disorder (PDD), sponsored by St. Luke's-Roosevelt Hospital Center. Started Jun 2002; status: completed.
02
Drugs
escitalopram
03
Conditions
persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00220701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220701.